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To the Editor: Xing et al. (1) 
conclude that evidence of infection 
with a severe fever with thrombocy-
topenia syndrome (SFTS)–like virus 
or Heartland-like virus (HRTV) was 
found in many captive large mammals 
from much of Minnesota, raising the 
specter of widespread distribution of a 
novel pathogen. Although it is likely 
that HRTV can be found beyond the 
areas in northwestern Missouri, where 
it was discovered (2), we contend that 
this conclusion is not substantiated 
by the data presented by Xing et al., 
which were generated by an assay that 
was developed to diagnose SFTS virus 
infections in China (1,3). The study 
used an ELISA developed for an SFTS 
virus recombinant nucleocapsid pro-
tein that detects SFTS-reactive anti-
bodies (3). The conclusions reached 
by Xing et al. are based on the as-
sumption that the SFTS assay devel-
oped in China will cross-react with 
HRTV antibodies (1). This assump-
tion remains unsupported because the 
SFTS assay has not been evaluated 
for cross-reaction with antibodies to 
other non-SFTS members of the ge-
nus Phlebovirus (1,3). In addition, it 
is well recognized that serologic tests, 
like the ELISA, are often group reac-
tive (4), requiring neutralization tests 
to confirm antibody presence and pro-
vide specificity. Alternative explana-
tions include the possibility that posi-
tive results from testing by Xing et al. 
may have been caused by cross-reac-
tion with antibodies directed against 
other known tick-associated phlebo-
viruses endemic to North America, 
such as Lone Star virus (5), which is 
not known to be pathogenic. In the ab-
sence of confirmatory data generated 
by an independent method, the report 
by Xing et al. (1) should be considered 
speculative. Reports suggesting sub-
stantial expansion in the geographic 
range of a pathogenic organism should 
be based on rigorously validated labo-
ratory methods.
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In Response: We welcome the 
critiques of Nasci et al. (1), who may 
have misinterpreted the point of our 
Dispatch. Regarding identification of 
Heartland virus (HLV) in farm ani-
mals, in our article (2), we stated that 
“the viruses detected in this region 
are most likely HLV or close rela-
tives of HLV,” which indicates that 
the exact identification of the viruses 
in the animals in Minnesota will not 
be confirmed until the viruses are iso-
lated and/or the genomic sequence 
data are available. 
The underlying data were ob-
tained with an ELISA specific to se-
vere fever with thrombocytopenia 
syndrome virus (SFTSV). The conclu-
sion was based on our knowledge, at 
the time our manuscript was submit-
ted, that in North America no other 
known phleboviruses of this expanded 
Uukuniemi group that contains SFTSV 
and HLV were reported to be cross-re-
active with SFTSV. When tested by us-
ing our reagent, SFTSV was not cross-
reactive with Rift Valley fever virus. 
Related phleboviruses of this group 
(e.g., Bhanja, Palma, Forecariah, and 
Kismayo viruses) have not been report-
ed in North America (3). Phleboviruses 
of this group, such as Murre virus and 
RML-105355 virus, and Sunday Can-
yon virus, were isolated in Alaska and 
Texas, respectively, but are not cross-
reactive with SFTSV (4). 
Other bunyaviruses in North 
America (e.g., Cache Valley virus and 
California serogroup viruses) are dis-
tantly related and have ≈11% amino 
acid sequence homology to SFTSV. 
The recently characterized Lone Star 
virus appears to be the closest relative 
to SFTSV and HLV and may cross-re-
act with SFTSV and HLV, as also sug-
gested by Nasci et al., but this virus is 
apparently known only from 1 isolate 
obtained in 1967 (5). These data sug-
gest that SFTSV is not serologically 
cross-reactive with the known Un-
kuniemi group viruses that are current-
ly being transmitted in North America. 
Our report shows that tickborne 
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